nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing for physiologic not chronologic age in the elderly
|
Henry, David H. |
|
2012 |
9 |
3 |
p. 75- 1 p. |
artikel |
2 |
Bench-to-bedside translation of targeted therapies in multiple myeloma
|
Anderson, Kenneth C. |
|
2012 |
9 |
3 |
p. 87-93 7 p. |
artikel |
3 |
Creating partnerships for survival
|
Sborov, Mark |
|
2012 |
9 |
3 |
p. 108-109 2 p. |
artikel |
4 |
Decitabine-induced acute lung injury
|
Marwaha, Monica |
|
2012 |
9 |
3 |
p. 106-107 2 p. |
artikel |
5 |
Don't shortchange older cancer patients
|
Lichtman, Stuart M. |
|
2012 |
9 |
3 |
p. 81-82 2 p. |
artikel |
6 |
Extramedullary BCR-ABL positive T-lymphoblastic leukemia in a patient with chronic myelogenous leukemia
|
Go, Mylene |
|
2012 |
9 |
3 |
p. 102-105 4 p. |
artikel |
7 |
How I treat … ASH
|
Askin, David |
|
2012 |
9 |
3 |
p. 112- 1 p. |
artikel |
8 |
Moving up in the world: screening for lung cancer
|
Streiner, David L. |
|
2012 |
9 |
3 |
p. 110-111 2 p. |
artikel |
9 |
Therapeutic optimization of aromatase inhibitor–associated arthralgia: etiology, onset, resolution, and symptom management in early breast cancer
|
Jones, Cheryl |
|
2012 |
9 |
3 |
p. 94-101 8 p. |
artikel |
10 |
Vemurafenib in melanoma with the BRAF V600E mutation
|
Abraham, Jame |
|
2012 |
9 |
3 |
p. 85-86 2 p. |
artikel |
11 |
Vemurafenib's companion assay refines use of the targeted therapy
|
Kirkwood, John M. |
|
2012 |
9 |
3 |
p. 83-84 2 p. |
artikel |